Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $91.90
- Average 1Y price target
- $124.71+35.70%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF1
- Return on equity2
- Return on assets2
- Debt / equity3
- P/E1
- P/B2
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 6 | $122.83 |
| Last year | 23 | $130.87 |
| All time | 34 | $118.41 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Oct 1, 2026 | UBS | downgrade | Buy | Neutral |
| Sep 9, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Sep 9, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Sep 9, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Sep 4, 2026 | Bernstein | upgrade | Underperform | Market Perform |
| Aug 10, 2026 | Barclays | maintain | Overweight | Overweight |
| Aug 7, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 16, 2026 | Barclays | maintain | Overweight | Overweight |
| May 18, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| May 8, 2026 | UBS | maintain | Buy | Buy |
| May 8, 2026 | JP Morgan | maintain | Neutral | Neutral |
| May 8, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 16, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Mar 3, 2026 | UBS | maintain | Buy | Buy |
| Mar 2, 2026 | Barclays | maintain | Overweight | Overweight |
| Feb 27, 2026 | Baird | maintain | Outperform | Outperform |
| Feb 18, 2026 | Citigroup | maintain | Neutral | Neutral |
| Feb 13, 2026 | Jefferies | downgrade | Buy | Hold |
| Jan 27, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jan 15, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 9, 2026 | TD Cowen | upgrade | Hold | Buy |
| Dec 18, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Nov 7, 2025 | UBS | maintain | Buy | Buy |
| Nov 7, 2025 | Barclays | maintain | Overweight | Overweight |
| Nov 5, 2025 | TD Cowen | maintain | Hold | Hold |
| Nov 5, 2025 | Roth Capital | maintain | Buy | Buy |
| Nov 5, 2025 | JP Morgan | maintain | Neutral | Neutral |
| Oct 16, 2025 | JP Morgan | maintain | Neutral | Neutral |
| Oct 7, 2025 | Jefferies | maintain | Buy | Buy |
| Sep 17, 2025 | Piper Sandler | upgrade | Neutral | Overweight |
| Aug 19, 2025 | Piper Sandler | maintain | Neutral | Neutral |
| Aug 8, 2025 | Barclays | maintain | Overweight | Overweight |
| Aug 5, 2025 | Roth Capital | maintain | Buy | Buy |
| Jul 30, 2025 | Baird | upgrade | Neutral | Outperform |
| Jul 24, 2025 | UBS | maintain | Buy | Buy |
| Jul 22, 2025 | JP Morgan | maintain | Neutral | Neutral |
| Jul 10, 2025 | Barclays | maintain | Overweight | Overweight |
| Jun 6, 2025 | Barclays | upgrade | Equal Weight | Overweight |
| May 8, 2025 | Barclays | maintain | Equal Weight | Equal Weight |